Page 132 - Magnesium-based supports for stem cell therapy of vascular disease - Mónica Echeverry Rendón

CHAPTER 8
Future perspectives
Our results provide a preliminary view on the future use and safety of the material in vivo which warrants valida- tion in animal models. We anticipate, based on published literature that in vivo results will be better than our in vitro data, due to the severe measurement conditions and other arguments that were mentioned previously.
The results in this thesis open the door to different routes. The surface modification of the Mg not only can be used in cardiovascular applications as described in this thesis. Yet, also other applications such as bone implants, surgical staples, wires, and other kinds of temporal and degradable implants are worth to consider. The challenge with this material lies in improvement of it mechanical properties and the design of the implant.
Additionally, this project allowed to explore the use of Mg in other presentations such as nanoparticles of Mg. Which can be used as a nanocarriers or deliver molecules or drugs to specific cells in order to kill or treat then selectively.
References
[1] WHO | World Health Statistics 2014, (n.d.). http://www.who.int/gho/publications/world_health_statis- tics/2014/en/#.VOLD0RNBb0s.mendeley (accessed February 17, 2015).
[2] M.H. Eng, D.E. Kandzari, Textbook of Cardiovascular Intervention, (2014). doi:10.1007/978-1-4471-4528-8.
[3] B.J. North, D.A. Sinclair, The intersection between aging and cardiovascular disease, Circ. Res. 110 (2012) 1097–1108.
[4] C. Chi, J. Snaith, J.E. Gunton, Diabetes medications and cardiovascular outcomes in Type 2 Diabetes, Hear. Lung Circ. 26 (2017) 1133–1141.
[5] C. Foundation, Heart Disease And Stroke Cost America Nearly $1 Billion A Day In Medical Costs, Lost Productiv- ity, (n.d.).
[6] B. O’Brien, W. Carroll, The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review., Acta Biomater. 5 (2009) 945–58. doi:10.1016/j.actbio.2008.11.012.
[7] J.P. Allain, M. Echeverry-rendón, J.J. Pavón, S.L. Arias, Nanostructured Biointerfaces, in: Nanopatterning Na- noscale Devices Biol. Appl., 2015: pp. 42–67.
[8] F. Witte, The history of biodegradable magnesium implants: a review., Acta Biomater. 6 (2010) 1680–92. d o i : 1 0 .1 0 1 6 / j . a c t b i o . 2 0 1 0 . 0 2 . 0 2 8 .
[9] K.W. Guo, A review of magnesium/magnesium alloys corrosion and its protection, Recent Pat. Corros. Sci. 2 (2010) 13–21.
[10] C. Liu, Y. Zhao, Y. Chen, P. Liu, K. Cai, Surface modification of magnesium alloy via cathodic plasma electroly- sis and its influence on corrosion resistance and cytocompatibility, Mater. Lett. 132 (2014) 15–18. doi:10.1016/j. matlet.2014.06.019.
[11] M. Bornapour, N. Muja, D. Shum-Tim, M. Cerruti, M. Pekguleryuz, Biocompatibility and biodegradability of Mg-Sr alloys: the formation of Sr-substituted hydroxyapatite., Acta Biomater. 9 (2013) 5319–30. doi:10.1016/j. a c t b i o . 2 0 1 2 . 0 7. 0 4 5 .
[12] N. Sezer, Z. Evis, S.M. Kayhan, A. Tahmasebifar, M. Koç, Review of magnesium-based biomaterials and their applications, J. Magnes. Alloy. (2018).
[13] A. Yabuki, M. Sakai, Anodic films formed on magnesium in organic , silicate-containing electrolytes, Corros. Sci. 51 (2009) 793–798. doi:10.1016/j.corsci.2009.02.001.
[14] A. Němcová, P. Skeldon, G.E. Thompson, B. Pacal, Effect of fluoride on plasma electrolytic oxidation of AZ61 magnesium alloy, Surf. Coatings Technol. 232 (2013) 827–838.
[15] J.M. Hernández-López, A. Němcová, X.L. Zhong, H. Liu, M.A. Arenas, S.J. Haigh, M.G. Burke, P. Skeldon, G.E. Thompson, Formation of barrier-type anodic films on ZE41 magnesium alloy in a fluoride/glycerol electrolyte,
130